Stem Cell TV | Video / Media News

Page 414«..10 20..413414415 416..420 430..»

More skin infection, less heart disease: study reveals how being tall affects health – The Guardian

Posted: June 4, 2022 at 2:12 am

Taller people have an increased risk of peripheral neuropathy, as well as skin and bone infections, but a lower risk of heart disease, high blood pressure and high cholesterol, according to the worlds largest study of height and disease.

A persons height raises and reduces their risk of a variety of diseases, according to the research led by Sridharan Raghavan of the Rocky Mountain Regional VA Medical Center in the US. The findings are published in the journal PLOS Genetics.

Height has been a factor associated with multiple common conditions, ranging from heart disease to cancer. But scientists have struggled to determine whether being tall or short is what puts people at risk, or if factors that affect height, such as nutrition and socioeconomic status, are actually to blame.

In the study, researchers set out to remove these confounding factors by looking separately at connections between various diseases and a persons actual height, and connections to their predicted height based on their genetics.

The team used data from the VA Million Veteran Program, including genetic and health information from more than 200,000 white adults and more than 50,000 black adults. The study looked at more than 1,000 conditions and traits, making it the largest study of height and disease to date.

The results confirmed previous findings from smaller studies that being tall is linked to a higher risk of atrial fibrillation and varicose veins, and a lower risk of coronary heart disease, high blood pressure and high cholesterol.

Researchers also uncovered new associations between being taller and a higher risk of peripheral neuropathy, which is caused by damage to nerves on the extremities, as well as skin and bone infections such as leg and foot ulcers.

The researchers now believe height may be a previously unrecognised risk factor for several common diseases. However, they cautioned that more studies were needed to clarify some of the findings, and future work would benefit from studying a more diverse international population.

We found evidence that adult height may impact over 100 clinical traits, including several conditions associated with poor outcomes and quality of life peripheral neuropathy, lower extremity ulcers, and chronic venous insufficiency, said Raghavan. We conclude that height may be an unrecognised non-modifiable risk factor for several common conditions in adults.

Read the original:
More skin infection, less heart disease: study reveals how being tall affects health - The Guardian

Posted in Genetics | Comments Off

CSU partners with American Hereford Association on genetics research – Beef Magazine

Posted: June 4, 2022 at 2:12 am

Colorado State University researchers are partnering with the American Hereford Association to support cattle producers and the beef industry in finding sustainable solutions to environmental and economic challenges.

The new research aims to enhance understanding of genetic differences in seedstock relative to enteric methane production and nitrogen excretion while identifying selection tools that can help reduce beef's carbon and environmental footprint.

"We're excited to begin this cooperative research agreement with Colorado State University,"says Jack Ward, executive vice president of the American Hereford Association, one of the largest beef breed associations in the United States. "It leverages decades of research and data collected by AHA members aimed at characterizing genetics associated with production efficiency, which plays a key role in environmental and economic sustainability."

Environmental and economic challengesDirect emissions from the animal agriculture sector account for 3.8% of U.S. greenhouse gas emissions, according to the Environmental Protection Agency. Enteric methane accounts for approximately 27% of methane emissions in the U.S.

Methane emission, as a genetic trait in cattle, appears to be moderately heritable with genetic correlations to economically relevant production traits, such as measures of growth, dry matter intake and various estimates of feed efficiency.

Worldwide attention is also focusing more intently on nitrogen a byproduct of rumen fermentation. Previous research suggests genetics play a significant role in nitrogen excretion by cattle, and when selected for, an individual animal's environmental footprint can be reduced.

"We know genetic improvement of our industry is driven by gains made in the seedstock sector. One only needs to look at changes in carcass meat yield and quality over the last two decades to realize the potential for improvements in seedstock genetics to transform the entire beef industry,"says Animal Sciences Professor Mark Enns, a beef cattle geneticist and key member of the research team.

Sustainable solutions"Often, we hear criticism leveled at the beef industry regarding greenhouse gas emissions and the impact of cattle on the environment, but with little context,"Enns says. "Cattle also sequester carbon and contribute to environmental health. This project will contribute to the beef cattle industry's goal of demonstrating carbon neutrality by 2040."

Given the Hereford breed's inherent genetic advantages associated with production efficiency, Ward says documenting the relationship between traits associated with efficiency and greenhouse gas emissions is logical next step for the breed and the industry.

"Beef industry stakeholders including the National Cattlemen's Beef Association have committed to improving the environmental impact of U.S. cattle production. This project aims to develop a selection tool for the American Hereford Association and the broader cattle industry that helps producers identify genetics that will have reduced greenhouse gas emissions without sacrificing animal productivity,"says Kim Stackhouse-Lawson, director of CSU AgNext, a pioneering research collaborative developing sustainable solutions for animal agriculture.

By leveraging existing animal performance data and monitoring animal emissions, Stackhouse-Lawson explains the goal is to identify genetic traits that influence environmental emissions from individual animals and then develop selection indices that can be used to reduce the environmental impact of cattle, while maintaining, and ideally improving economic returns to producers.

"This project will also position the American Hereford Association as a sustainability leader in the beef industry through the development of genetic selection tools that can identify and inform breeders of genetics that meet climate goals without sacrificing quality, performanceand efficiency," says Stackhouse-Lawson.

Further, Enns notes the project has potential to pave new paths of revenue for cattle producers. These could include such things as verified sustainable production claims, in addition to commonly discussed carbon credits.

Supporting the beef industryThe U.S. beef cattle industry has a long history of demonstrating extraordinary gains in efficiency over time, using genetics, technology and management to produce more beef with fewer cows and less land.

"This research will help us identify ways to magnify the gains the industry has already achieved," Ward says.

"CSU is involved in this project because we are passionate about beef production and the beef industry, and the societal benefits it brings from the upcycling of human-inedible plant materials and byproducts into high-quality protein,"Enns says. "From a genetic improvement standpoint, CSU has a long history of new trait development and delivery of selection tools to the industry. As such, we feel we have much to contribute in this realm, striving to produce cattle that meet consumer demands, yet have a smaller environmental footprint."

Source: Colorado State University, whichis solely responsible for the information provided, and wholly owns the information. Informa Business Media and all its subsidiaries are not responsiblefor any of the contentcontained in this information asset.

Posted in Genetics | Comments Off

MYRIAD GENETICS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and…

Posted: June 4, 2022 at 2:12 am

ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors;Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) and (c)

(e)

ITEM 5.07 Submissions of Matters to a Vote of Security Holders

The following is a brief description of each matter submitted to a vote at theAnnual Meeting, as well as the number of votes cast for and against and thenumber of abstentions and broker non-votes with respect to each matter.

Proposal No. 1: Election of Directors

Proposal No. 3: Approval, on an Advisory Basis, of the Compensation of Our NamedExecutive Officers, as Disclosed in the Proxy Statement

--------------------------------------------------------------------------------

ITEM 9.01 Financial Statements and Exhibits.

(+) Management contract or compensatory plan arrangement

--------------------------------------------------------------------------------

Edgar Online, source Glimpses

See the rest here:
MYRIAD GENETICS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and...

Posted in Genetics | Comments Off

Be the Match is looking for more ethnically diverse donors to help patients with blood cancers and diseases – KARE11.com

Posted: June 4, 2022 at 2:10 am

In Communities that KARE, a 9-year-old who needs a blood stem cell transplant is traveling the country to find donors, not just for him but for others too.

BLOOMINGTON, Minnesota Nine-year-old Alfredo Torres has a big appetite for food, Chicago Bulls basketball, and music. He loves to wrestle and play soccer with his cousins and run.

But what sets this 4th grader from Chicago apart from other kids his age is that he lives with a blood disorder and needs a blood stem cell transplant.

A blood stem cell transplant replaces a patient's unhealthy blood-forming cells with healthy ones from their donor. The cells used in transplants come from peripheral blood stem cells (PBSC), marrow, and umbilical cord blood. A successful transplant can cure or treat more than 75 diseases, including leukemia and lymphoma, aplastic anemia, sickle cell, and immune-deficiency disorders.

Alfredo and his mom Natalia Torres traveled to Minnesota to raise awareness for Be the Match, a Twin Cities-based nonprofit supporting patients battling blood cancers and disorders.

"He's full of life. He wants to live," said Torres. "He gets infections; he gets sick real quick because his immune system is suppressed."

Be the Match runs a national registry of potential donors for bone marrow and blood stem transplants. They also search international registries with access to more than 39 million people.

Still, some patients have a hard time finding a match. "We're searching for [a] possible donor from a Hispanic donor because we're Hispanics," said Torres.

The likelihood of finding a matching donor ranges from 29% to 70%, depending on ethnic background. "When we look across the spectrum, our lowest chance of finding a match is for Black and African American patients at 29%," explained Alex Mensing, director of benefactor engagement for Be the Match. "Really, the answer to that is more diverse registry members joining."

The Mall of America is joining the cause by partnering with Be the Match for a unique campaign called 30,000 lifesavers.

Shoppers can join the registry at on-site events throughout the year or make a financial donation. "We fully fund patient assistance for our patients and their families. As everybody knows, cancer treatment, [and] blood disease treatment is not cheap," said Mensing.

Every dollar Be the Match raises helps more patients afford transplants, adds potential blood stem cell donors to the registry, and funds research. In 2021, Be The Match provided $6.1 million in patient assistance to 2,600 families.

The burden is heavy for families, and instead of just waiting for a call, the Torres family calls for action. "We just need to raise awareness for these patients in need."

Adults can donate one of two ways. First, about 85% of the time, a patient's doctor requests a PBSC donation, a non-surgical, outpatient procedure similar to donating platelets or plasma.

About 15% of the time, a patient's doctor requests marrow, a surgical, outpatient procedure at a hospital. General or regional anesthesia is always used.

Adults between the ages of 18-40 who meet health guidelines can join the Be The Match Registry for no cost by visiting BeTheMatch.org. Registration involves completing a health history form and giving a swab of cheek cells. People between 18 and 35 are most urgently needed since they are requested by transplant doctors most often, and research shows that these donors provide the best chance for transplant success.

Another way Be the Match helps patients is by organizing couriers who hand-deliver the donated cells, transported as quickly and safely as possible to a patient in need across the country and the world. That life-saving transport happens around 15 times a day.

Watch all of the latest stories from Communities that KARE in ourYouTube playlist:

View original post here:
Be the Match is looking for more ethnically diverse donors to help patients with blood cancers and diseases - KARE11.com

Posted in Minnesota Stem Cells | Comments Off

Neoantigen Targeted Therapies Market Analysis and Opportunity Assessment up to 2027 – BioSpace

Posted: June 4, 2022 at 2:09 am

Wilmington, Delaware: Substantial developments in neoantigen targeted therapies have helped in adoption of personalized treatment approaches. These therapies have shown a noteworthy result in the treatment of cancer in several cases. Neoantigen-targeted therapies help in curing cancer by improving the response of immune system and generating new immune responses.

Read Report Overview - https://www.transparencymarketresearch.com/neoantigen-targeted-therapies-market.html

At present, there are several therapies that are under investigation by researchers along with several checkpoint inhibitors.

An upcoming report on the neoantigen targeted therapies market is expected to offer an in-depth analysis of key industry aspects. The report highlights the capabilities of various stakeholders in the market and latest strategies adopted by them. The report is recommended to readers who are associated with the neoantigen targeted therapies market directly and indirectly.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=71304

Neoantigen Targeted Therapies Market: Notable Developments and Competitive Landscape

The vendor landscape of the neoantigen targeted therapies market is moderately consolidated with a few players enjoying the majority of market share. Some of the prominent players operating in the neoantigen targeted market are Bavarian Nordic, Gradalis, Genocea Biosciences, Immunicum, Immunovative Therapies, and Iovance Biotherapeutics.

These players are expected to indulge in collaboration and geographical expansion of their business. Further, giant players are increasing their focus on the advanced research and development activity.

For example, in May 19, Genocia, a key player in the neoantigen targeted therapies market, collaborated with a Iovance to research on the tumor-infiltrating lymphocytes(TIL). This will help Genocia explore and develop neoantigen for TIL. Such developments in the neoantigen targeted therapies market are expected to offer several lucrative prospect for the growth of the global neoantigen targeted therapies market.

Request for Analysis of COVID-19 Impact on Neoantigen Targeted Therapies Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=71304

Neoantigen Targeted Therapies Market: Key Trends

Neoantigen targeted therapies are an advanced form of dealing with the several immunity disorder and cancer. The therapy improves the response of the bodys immune system and promotes long term growth of activated T cells.

The incompetency of the other cancer treatment therapies such as chemotherapy on the cancer patients calls for more effective treatment. This opens several lucrative opportunities for the growth of the neoantigen targeted therapies market in the coming years.

Along with this, factors such as prevalence of cancer and rise in geriatric population across the globe are expected to fuel the neoantigen targeted therapies market. This is because the immunity system of the geriatric people is weak and their body lack desired energy required to resist chemo drugs. In such situation, neoantigen targeted therapies are possible solution for the treatment of the cancer.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=71304

Despite several opportunities, neoantigen targeted therapies are at present at its nascent stage. Hence there is scarcity of resource in the market.

Nonetheless, increasing popularity and growing consumer awareness are expected to boost the prospects of the neoantigen targeted therapies market in the coming few years.

Pre Book Neoantigen Targeted Therapies Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=71304&ltype=S

Neoantigen Targeted Therapies Market: Regional Outlook

On the basis of region, North America is anticipated to lead in terms of market share during the forecast period. This is mainly because of presence of maximum consumer pool in the region. In addition to this, factors such as well-developed healthcare infrastructure, early adoption of advanced technology, and favorable government reimbursement plan are expected to play a significant role in the growth of the global neoantigen targeted therapies market.

More Trending Reports by Transparency Market Research:

Particle Therapy Market: Increase in adoption of particle therapy along with advantages such as high precision, shorter treatment duration, and lower side-effects compared to conventional photon therapies using X-rays are expected to drive the global particle therapy market from 2022 to 2031

Radiation Therapy Market: Increase in incidence and prevalence rates of cancer in developing and developed countries across the world, rise in technological advancements, and surge in health care spending are projected to boost the global radiation therapy market during the forecast period.

Combination Antibody Therapy Market: The global combination antibody therapy market has undergone revolutionary progress in the past few years owing to continued focus on development of targeted cancer therapies that lead to fewer side effects.

Canine Stem Cell Therapy Market: The global canine stem cell therapy market has seen vast developments in the past few years in terms of the technology available for obtaining, preserving, and using stem cells.

Erectile Dysfunction Shockwave Therapy Market: The global erectile dysfunction shockwave therapy market is driven by high prevalence and rise in incidence rate of erectile dysfunction across the globe.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Rohit BhiseyTransparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

See more here:
Neoantigen Targeted Therapies Market Analysis and Opportunity Assessment up to 2027 - BioSpace

Posted in Delaware Stem Cells | Comments Off

Microscopy Devices Market Competitive Insights and Precise Outlook 2021-2028 Industrial IT – Industrial IT

Posted: June 4, 2022 at 2:09 am

Microscopy Devices Market Outlook 2028

Analysts Viewpoint on Microscopy Devices Market Scenario

Companies in the global microscopy devices market should accelerate their product development and unlock revenue opportunities to obtain competitive benefits. Market stakeholders are extending their services arms to gain competitive edge in the healthcare sector. Increasing incidences of diseases and rising applications of microscopic devices are driving the global market. Market contributors in the global microscopy devices market should focus on the production of cost-efficient microscopy devices. Rising prices of electron microscopes and scanning probe microscopes hamper the growth of the global microscopy devices market.

Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=226

Impact of COVID-19 on Global Microscopy Devices Market

With significant impact on the global economy and businesses, the coronavirus pandemic has put intense pressure on medical & healthcare systems. The global microscopy devices market is negatively affected due to the coronavirus pandemic. Shortage of raw materials required for microscopy devices and disrupted supply chain have hampered the growth of the global microscopy devices market. However, due to significant efforts taken by healthcare providers and market stakeholders, the global microscopy devices market is expected to show potential growth opportunities in the upcoming years.

The increasing demand for integrated microscopes in research laboratories, hospitals, and diagnostic laboratories is driving the global market. Manufacturers operating in the global microscopy devices are focusing on product innovations due to growing demand at the global level. In addition, microscopic devices are increasingly being used in nanotechnology and semiconductor industries.

Growth and Advancement in Semiconductor Industry to Boost Market Growth

The global microscopy devices market is projected to witness value-grab opportunities in the near future, owing to increasing investments in research laboratories, healthcare advancement, and rising prevalence of diseases across the globe. With rapid advancements in technology, research & development activities are also increasing in developing countries. Moreover, application of microscopes in the semiconductor industry is rising. These devices are widely being used in the semiconductor industry for research & development, quality checking, monitoring, quality control, analysis of process development, etc.

The increasing popularity of nanotechnology,quantum dots, and optoelectronics boosts the demand for microscopic devices.

Increasing Demand Due to Rising Applications in Life Sciences

Manufacturers operating in the global microscopy devices market are increasing their production portfolio to fulfill the demand from healthcare and life sciences sectors. Microscopes are popularly used in the field of cellular biology for stem cells and cancer cells research. Growth and advancement in the field of biomedical engineering boost the demand for microscopy devices. Due to various benefits and unique properties of these microscopic devices, many diagnostic laboratories, ambulatory surgery centers, and physicians make use of them for research and analysis. Fluorescence microscopes, electron microscopes, microscopy accessories, and optical microscopes are extremely beneficial for the biomedical and biological research applications. This growth is expected to continue in the foreseeable future, which, in turn, drives the global microscopy devices market.

Expanding Contact Research Organizations (CROs) Drives Market Growth

Manufacturers operating in the global microscopy devices market are bolstering their research & development capabilities to experiment with new technologies and applications. Microscopy devices companies are establishing their foot in outsourcing R&D activities from various contact research organizations to stay ahead of the competition and generate more revenue opportunities.

Increasing government expenditure on healthcare and research & development activities strengthens the scope and expansion of contact research organizations. Many CROs provide clinical-study and clinical-trial support for different medical devices such as microscopy devices.

In addition, emerging contract research organizations in developing nations are attracting new players in the global microscopy devices market. Several pharmaceutical and biotechnology companies are outsourcing their R&D in order to focus on core business segments, and reduce manpower and other expenditure. This has encouraged CROs to expand their field of expertise and solutions, enter diverse research segments, and provide a range of R&D solutions to the companies.

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=226

Opportunities for Prominent Market Players in North America

The increasing presence of highly developed research institutes and laboratories in North America is a major factor driving the microscopy devices market in the region. Investments on R&D, availability of advanced microscopy devices by top market leaders, and rising focus on nanotechnology are some of the factors positively contributing to the market growth in North America.

Growing adoption of technologically advanced microscopy devices such as electron microscopy, scanning probe microscopy, etc., and advancements in life sciences and pharmaceutical industries further boost market growth. However, high cost of advanced microscopy devices and high customs duty & excise tax are factors affecting the growth of the market in North America. Top players in the microscopy devices market are focusing on various strategies to strengthen their market presence.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Rohit Bhisey

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Email: [emailprotected]sparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Biospace Links

https://www.biospace.com/article/inactivated-vaccines-market-rise-in-awareness-among-people-about-immunization-to-drive-the-market/

Read the original:
Microscopy Devices Market Competitive Insights and Precise Outlook 2021-2028 Industrial IT - Industrial IT

Posted in Delaware Stem Cells | Comments Off

Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of Metastatic Castration-Resistant Prostate Cancer -…

Posted: June 4, 2022 at 2:07 am

BROOKLYN, N.Y.--(BUSINESS WIRE)--Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AC0176 for the treatment of patients with metastatic castration resistant prostate cancer (mCRPC) with disease progression on or after treatment with androgen receptor signaling inhibitors. AC0176 is an orally bioavailable, chimeric degrader molecule targeting the androgen receptor (AR). AC0176 is currently being evaluated in a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity in patients with mCRPC.

mCRPC is a devastating cancer for men marked by high recurrence rate and poor survival. Receiving Fast Track designation from the FDA highlights the high unmet medical need for mCRPC and acknowledges the potential of AC0176 as a novel treatment for this patient population, said Jie Fan, Ph.D., Chief Executive Officer of Accutar Biotechnology, Inc. "AC0176 was designed to potently degrade both AR wildtype and prevalent AR mutations which confer drug resistance to current AR signaling inhibitors. We look forward to continued interaction with FDA as we quickly advance the development of this potentially promising treatment option for patients in need.

About Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Prostate cancer (PC) is the second most commonly diagnosed cancer among men worldwide, and the first among men in the United States. mCRPC is a lethal diagnosis, and more effective therapeutic approaches are urgently needed for patients, particularly those who progressed on AR signaling inhibitors. AR-reactivating mechanisms conferring resistance to AR signaling inhibitors include, AR amplification and overexpression, AR point mutations, AR splicing variants, intra-tumoral androgen synthesis, promiscuous AR activation by other factors, etc.

About AC0176

AC0176 is an investigational orally bioavailable, chimeric degrader of AR for the potential treatment of prostate cancers. In preclinical studies, AC0176 demonstrated potent and selective AR protein degradation, favorable pharmacological properties, as well as promising anti-tumor activity in animal models. AC0176 was designed to have broad coverage of AR wildtype and prevalent AR mutations, including but not limited to L702H, T878A, H875Y, W742C. AC0176 is being evaluated in a Phase 1 clinical trial, and information on the study can be found on http://www.clinicaltrials.gov (NCT05241613).

About Accutar Biotechnology, Inc.

Accutar is a clinical stage biotech company focused on AI-enabled drug discovery, and its application to the discovery and development of clinically differentiated medicines.

Be transformative. For patients.

To learn more about Accutar, please visit us at http://www.accutarbio.com.

Posted in Biotechnology | Comments Off

G7 heads call for decarbonisation of industry – European Biotechnology News

Posted: June 4, 2022 at 2:07 am

G7 Climate, Energy and Environment Ministers have announced a wide range of actions to tackle the triple global crisis of climate change, biodiversity loss and pollution".

The G7 ministers underlined the importance of efforts to improve energy efficiency, the need for increased investment in renewable energy, tracking of methane emissions. They also highlighted that it will be important to reduce the EUs reliance on Russian natural gas and oil. In their final communiqu they devoted particular attention the Internnational Energys (IEA) recent report on "Achieving Net Zero Heavy Industry Sectors in G7 Members", which was produced at the request of Germanys G7 Presidency. The report lays out a series of recommendations for G7 economies to advance the transition towards near zero emission steel and cement production as well as in the energy sector.

IEA Executive Director Fatih Birol stressed that the world does not need to choose between the energy crisis and the climate crisis. We can solve both of them with the right investment. Dr Birol urged decision makers not to lock in our future by using the current situation as an excuse to justify investments in large, long-term fossil fuel projects that are inconsistent with efforts to reduce global emissions to net zero.

However, neither the G7 ministers nor Fatih mentioned the biotech "drop-in" solutions that already exist or are about to be launched. These could help reduce growing CO2 emissions immediately while reducing dependence on Russian gas and oil. For example, U.S. biotech firm Lanzatech Inc has established a microbial production platform that can produce chemicals and fuels such as biobutanol with identical energy content to gasoline while consuming and sequestering atmospheric carbon dioxide. On an industrial scale, the company is already producing bioethanol as an admixture for aviation fuel from the exhaust gases of Chinese steelworks in cooperation with Shell and Vattenfall. Biobutanol coming to market next year will have the same energy density as gasoline and could help neutralize CO2 emissions from both the transportation and energy sectors at current levels, if broadly applied.

In addition, Austria's Krajete GmbH has been marketing for a decade a microbial process that produces biomethane on an industrial scale from carbon dioxide emissions and hydrogen, which can be injected into the natural gas grid and could dramatically reduce dependence on Russian gas imports.

In the construction sector, U.S. company Biomanson is commercialising a microbial production process for bioconcrete that binds atmospheric CO2 instead of emitting it. Its stated goal is to cut a quarter of the global CO2 emissions by the construction industry by 2030.

In the food and feed sector, companies such as Deepbranch (UK), Solar Foods (Finland) or Austria's Arkeon Biotechnologies have developed technologies to produce amino acids and proteins from CO2 and H2 that can help drastically curb high-emission factory farming by producing meat alternatives that are land- and commodity-price neutral.

What the processes of industrial biotechnology, so far largely ignored by the EU Commission in favour of agricultural solutions, are capable of achieving will be presented at the Industria Biotec event in Berlin on 7 October. Some of this can be read in European Biotechnology.According to a report published today by the European Court of Auditors, the EU has failed to meet its self-imposed target of spending at least 20% of its money on climate action between 2014 and 2020. while the European Commission claimed the EU spent 216bn on climate action during the period, meeting the 20% target, the auditors found that the reported spending was not always climate-relevant and that the total amount of climate change spending was overstated by at least 72bn. They also expressed concern that the Commission's figures could also be unreliable for the period 2021-2027, when the EU's climate change spending target will be even higher - at 30%. This shows that tackling the climate crisis is not as high on the political agenda as stated publicly.

According to leading climate scientists, the facts have been on the table for 50 years. They cannot explain policy inaction and point to the need for immediate action to limit global warming to 2C above pre-industrial levels

Visit link:
G7 heads call for decarbonisation of industry - European Biotechnology News

Posted in Biotechnology | Comments Off

Biotechnology Reagents Market Report: Exponential Growth by Market Size, Share, Trends and Analysis to 2028 The Greater Binghamton Business Journal -…

Posted: June 4, 2022 at 2:07 am

The quality of Global Biotechnology Reagents Market market research report is at par which gains customer confidence and trust. This market report directs business in right direction by giving insights about products, market, customers, competitors and marketing strategy at right time. Hence it acts as a backbone to the business. This market report helps to develop a successful marketing strategy for the business. The business report is very helpful to all sizes of business which makes it simpler to take informed decisions in providing the different aspect of HEALTHCARE industry. The worldwide Global Biotechnology Reagents Market market report contains all the company profiles of the major players and brands.

Download Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-biotechnology-reagents-market&kb

The Global Biotechnology Reagents Market market report also indicates a narrowed decisive summary of the market. Along with this, multiple factors which have affected the advancement and improvement in a positive as well as negative manner are also studied in the report. On the contrary, the various factors which will be acting as the opportunities for the development and growth of the Global Biotechnology Reagents Market market in the forecasted period are also mentioned.

A combination of best industry insight, practical solutions, talent solutions and latest technology has been used to structure an excellent Global Biotechnology Reagents Market market report. Thoroughly analysed market segmentation aspect provides a clear idea about the product consumption based on several factors ranging from type, application, deployment model, end user to geographical region. Moreover, drivers and restraints of the market assessed in this wide ranging report makes aware about how the product is getting utilized in the recent market environment and also provide estimations about the future usage. The proper utilization of established statistical tools and coherent models for analysis and forecasting of market data makes Global Biotechnology Reagents Market marketing report outperforming.

Top Keyplayers in Global Biotechnology Reagents Market Report:

Abbott, Agilent Technologies Inc., Danaher, BD, Bio-Rad Laboratories Inc., General Electric, bioMrieux SA, LONZA, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hoefer, Inc., Meridian Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Promega Corporation, Quality Biological, Siemens AG, Bio-Techne, TAKARA HOLDINGS INC., Sysmex Corporation, Tosoh Corporation, WATERS, W. R. Grace & Co.-Conn., Ortho Clinical Diagnostics, Olympus Corporation and Fitzgerald Industries International

Scope:

Feel Free To Ask Question Before Purchasing The Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biotechnology-reagents-market&kb

Regional Analysis

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Request for TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biotechnology-reagents-market&kb

An excellent Global Biotechnology Reagents Market market research report has several benefits which can be projected to wide-ranging aspects of HEALTHCARE industry. It helps to draw target audiences for the clients before launching any advertising campaign. With the market report, it becomes easy to collect industry information more quickly. Moreover, this industry analysis report also solves the purpose of validating the information that has been gathered through internal or primary research. With the finest Global Biotechnology Reagents Market market report, it becomes possible to achieve holistic view of the market effectively and then also benchmark all the companies in the HEALTHCARE industry.

Highlights of TOC:

Chapter 1: Market overview

Chapter 2: Global Induction Global Biotechnology Reagents Market market analysis

Chapter 3: Regional analysis of the Induction Global Biotechnology Reagents Market industry

Chapter 4: Market segmentation based on types and applications

Chapter 5: Revenue analysis based on types and applications

Chapter 6: Market share

Chapter 7: Competitive Landscape

Chapter 8: Drivers, Restraints, Challenges, and Opportunities

Chapter 9: Gross Margin and Price Analysis

Goals and objectives of the Global Biotechnology Reagents Market Market Study

Understanding the opportunities and progress of Global Biotechnology Reagents Market Global Biotechnology Reagents Market market highlights, as well as key regions and countries involved in market growth.

Study the different segments of the Global Biotechnology Reagents Market market and the dynamics of Global Biotechnology Reagents Market in the market.

Categorize Global Biotechnology Reagents Market segments with increasing growth potential and evaluate the futuristic segment market

To analyze the most important trends related to the different segments that help to decipher and convince the Global Biotechnology Reagents Market market.

To verify region-specific growth and development in the Global Biotechnology Reagents Market market.

Understand the key stakeholders in the Global Biotechnology Reagents Market market and the value of the competitive image of the Global Biotechnology Reagents Market market leaders.

To study key plans, initiatives and strategies for the development of the Global Biotechnology Reagents Market market.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-biotechnology-reagents-market?kb

How DBMR is different than other Market Research Providers:

The inception of DBMR has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

https://www.databridgemarketresearch.com/reports/global-connected-health-personal-medical-devices-market

https://www.databridgemarketresearch.com/reports/global-botulism-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com

Read the original here:
Biotechnology Reagents Market Report: Exponential Growth by Market Size, Share, Trends and Analysis to 2028 The Greater Binghamton Business Journal -...

Posted in Biotechnology | Comments Off

Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Size, Scope and Forecast | Danaher Corporation, Thermo Fisher Scientific,…

Posted: June 4, 2022 at 2:07 am

New Jersey, United States TheMalaysia Pharmaceutical & Biotechnology Environmental Monitoring Marketreport is the result of extensive and expert research into theMalaysia Pharmaceutical & Biotechnology Environmental Monitoringindustry. TheMalaysia Pharmaceutical & Biotechnology Environmental MonitoringMarketreport explains what the market is all about, the market prognosis, several segmentations, and everything that falls under the markets umbrella. It also looks at major and secondary market drivers, market share, potential sales volume, regional analysis, and the markets key segments. The research also includes key variables that contribute to the markets growth as well as elements that might stifle the markets growth. The professionals at VM Reports applied precise research techniques and other analyses.

PESTLE analysis and SWOT analysis are two of the analyses utilized in theMalaysia Pharmaceutical & Biotechnology Environmental MonitoringMarketresearch, and they shed light on numerous internal and external variables that affect the market in every situation. It also includes a section that identifies strengths, weaknesses, opportunities, and threats, as well as Porters five forces model.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.verifiedmarketresearch.com/download-sample/?rid=89880

There is also a section dedicated to significant actors and their plans, such as acquisitions, collaborations, and so on. The material in the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market research was gathered mostly via expert opinions, interviews, and surveys. Verified Market Research experts have created a Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market research that is full of clarity, accuracy, and useful information. The data in the report is quite accurate and reliable, with no duplicates or mistakes.

Key Players Mentioned in the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Research Report:

Danaher Corporation, Thermo Fisher Scientific, Merck Kgaa, Eurofins Sinensis, Lonza, Biomerieux, Vai, Cosasco, Rmoni and Amphenol Corporation

Malaysia Pharmaceutical & Biotechnology Environmental MonitoringMarket Segmentation:

Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market, By Type

Monitoring Equipment Media Software Microbiology Services

Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market, By Application

Pharmaceutical Industry Biotechnology Industry Academic & Research Institutes

Inquire for a Discount on this Premium Report@ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=89880

Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Report Scope

Key questions answered in the report:

1. Which are the five top players of the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market?

2. How will the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market change in the next five years?

3. Which product and application will take a lions share of the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market?

4. What are the drivers and restraints of the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market?

5. Which regional market will show the highest growth?

6. What will be the CAGR and size of the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market throughout the forecast period?

For More Information or Query or Customization Before Buying, Visit @ https://www.verifiedmarketresearch.com/product/malaysia-pharmaceutical-biotechnology-environmental-monitoring-market/

Visualize Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market using Verified Market Intelligence:-

Verified Market Intelligence is our BI-enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

Visualize Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market using VMI @ https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research

Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. We offer insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecast, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.

We, at Verified Market Research, assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.

Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the worlds leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.

Mr. Edwyne Fernandes

Verified Market Research

US: +1 (650)-781-4080UK: +44 (753)-715-0008APAC: +61 (488)-85-9400US Toll-Free: +1 (800)-782-1768

Email: sales@verifiedmarketresearch.com

Website:- https://www.verifiedmarketresearch.com/

Continued here:
Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Size, Scope and Forecast | Danaher Corporation, Thermo Fisher Scientific,...

Posted in Biotechnology | Comments Off

Page 414«..10 20..413414415 416..420 430..»

More skin infection, less heart disease: study reveals how being tall affects health – The Guardian

CSU partners with American Hereford Association on genetics research – Beef Magazine

MYRIAD GENETICS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and…

Be the Match is looking for more ethnically diverse donors to help patients with blood cancers and diseases – KARE11.com

Neoantigen Targeted Therapies Market Analysis and Opportunity Assessment up to 2027 – BioSpace

Microscopy Devices Market Competitive Insights and Precise Outlook 2021-2028 Industrial IT – Industrial IT

Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of Metastatic Castration-Resistant Prostate Cancer -…

G7 heads call for decarbonisation of industry – European Biotechnology News

Biotechnology Reagents Market Report: Exponential Growth by Market Size, Share, Trends and Analysis to 2028 The Greater Binghamton Business Journal -…

Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Size, Scope and Forecast | Danaher Corporation, Thermo Fisher Scientific,…

Categories

Archives

Recommended Sites

Contact Us

Recent Posts